A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)
Clinical trial NCT03492281 · COMPLETED
Trial details
- NCT number
- NCT03492281
- Sponsor
- Urovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2019-01-10
- Enrollment
- 1530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.